Abstract:In this study, we present a technique that spans multi-scale views (global scale -- meaning brain network-level and local scale -- examining each individual ROI that constitutes the network) applied to resting-state fMRI volumes. Deep learning based classification is utilized in understanding neurodegeneration. The novelty of the proposed approach lies in utilizing two extreme scales of analysis. One branch considers the entire network within graph-analysis framework. Concurrently, the second branch scrutinizes each ROI within a network independently, focusing on evolution of dynamics. For each subject, graph-based approach employs partial correlation to profile the subject in a single graph where each ROI is a node, providing insights into differences in levels of participation. In contrast, non-linear analysis employs recurrence plots to profile a subject as a multichannel 2D image, revealing distinctions in underlying dynamics. The proposed approach is employed for classification of a cohort of 50 healthy control (HC) and 50 Mild Cognitive Impairment (MCI), sourced from ADNI dataset. Results point to: (1) reduced activity in ROIs such as PCC in MCI (2) greater activity in occipital in MCI, which is not seen in HC (3) when analysed for dynamics, all ROIs in MCI show greater predictability in time-series.
Abstract:Our study aims to utilize fMRI to identify the affected brain regions within the Default Mode Network (DMN) in subjects with Mild Cognitive Impairment (MCI), using a novel Node Significance Score (NSS). We construct subject-specific DMN graphs by employing partial correlation of Regions of Interest (ROIs) that make-up the DMN. For the DMN graph, ROIs are the nodes and edges are determined based on partial correlation. Four popular community detection algorithms (Clique Percolation Method (CPM), Louvain algorithm, Greedy Modularity and Leading Eigenvectors) are applied to determine the largest sub-community. NSS ratings are derived for each node, considering (I) frequency in the largest sub-community within a class across all subjects and (II) occurrence in the largest sub-community according to all four methods. After computing the NSS of each ROI in both healthy and MCI subjects, we quantify the score disparity to identify nodes most impacted by MCI. The results reveal a disparity exceeding 20% for 10 DMN nodes, maximally for PCC and Fusiform, showing 45.69% and 43.08% disparity. This aligns with existing medical literature, additionally providing a quantitative measure that enables the ordering of the affected ROIs. These findings offer valuable insights and could lead to treatment strategies aggressively targeting the affected nodes.